Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001969223-25-000850
Filing Date
2025-10-15
Accepted
2025-10-15 16:20:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4707
  Complete submission text file 0001969223-25-000850.txt   6141
Mailing Address 116 HUNTINGTON AVENUE SUITE 703 BOSTON MA 02116
Business Address 116 HUNTINGTON AVENUE SUITE 703 BOSTON MA 02116 617-468-4219
Bicara Therapeutics Inc. (Subject) CIK: 0002023658 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-42271 | Film No.: 251395054
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address BICARA THERAPEUTICS INC. 116 HUNTINGTON AVENUE, SUITE 703 BOSTON MA 02116
Business Address
Cohlhepp Ryan (Reporting) CIK: 0002034665 (see all company filings)

Type: 144